Command Palette

Search for a command to run...

Clinical Trials · NCT02660047

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Leiden University Medical Center
Enrollment
51
Start date
Aug 2015
Locations
1 site, Netherlands
Primary endpoint
Stroke volume
View Liraglutide compound reference